UC San Diego scientists showed a natural enzyme can read an eight-letter genetic alphabet, hinting at tools that could rewrite medicine and biotech.
Story Snapshot
- UC San Diego team reports accurate transcription of an eight-letter DNA alphabet by a natural bacterial enzyme.
- High-resolution imaging shows how the enzyme recognizes synthetic base pairs.
- Nature Communications is identified as the publishing journal for the study.
- Potential uses include better diagnostics, new treatments, and engineered biology.
What The Researchers Did And Found
UC San Diego researchers studied a core cell enzyme called RNA polymerase from Escherichia coli. The team tested whether this natural enzyme could read DNA that uses eight letters instead of the usual four. The added letters come from a system known as hachimoji DNA. The group reports that the enzyme accurately read these templates and produced matching RNA. The report identifies Nature Communications as the journal for the study and highlights accurate transcription as the key outcome.
The researchers used high-resolution cryo-electron microscopy to see how the enzyme handled the new letters. These images captured structural snapshots while the enzyme worked. The pictures suggest the enzyme recognizes the synthetic base pairs using signals similar to those used for natural pairs. That gives a physical reason why transcription can proceed without engineered parts. This structural view supports the claim that a normal enzyme can process expanded genetic information in the lab setting.
Why An Eight-Letter Alphabet Matters
Every known organism uses four DNA letters to store and pass on genetic information. Scientists have long explored adding new letters to expand what DNA can do. Earlier work showed eight-letter systems can form stable structures and even produce working RNA aptamers with engineered enzymes. The new result matters because it uses a natural bacterial enzyme to read these letters. That step could make lab tools simpler and cheaper, and could speed progress toward useful tests and treatments.
Added letters can increase the range of shapes and signals that DNA and RNA can make. That can help build sensors that detect disease markers that current tools miss. It can also help craft drug-like molecules that bind targets more tightly. Reviews of the field describe expanded alphabets as platforms to store and handle more information than natural DNA. This study fits that arc by showing a key part of the central dogma can work with extra letters using a normal enzyme.
Practical Uses And Realistic Limits
The UC San Diego team and coverage point to gains in diagnostics, therapeutics, and engineered biology. Better diagnostics could come from probes that are more specific, reducing false positives. New treatments could include RNA guides or aptamers tuned with extra letters to boost binding and reduce side effects. Engineered biology could get safer genetic “locks,” where added letters prevent cross-talk with natural genomes. These potential uses align with the reported advance in accurate transcription.
Researchers at UC San Diego have demonstrated that a key cellular enzyme can accurately read an eight-letter genetic alphabet, doubling the four letters used by all known life on Earth. Detailed imaging revealed that RNA polymerase handles synthetic DNA lehttps://t.co/zfH9aiRbWV
— Michael W. Deem (@Michael_W_Deem) September 5, 2026
The current reporting centers on controlled laboratory tests. The materials do not show results inside living cells, and they do not provide numeric error rates in this package. That means the work is an enabling step, not a finished system for heredity or growth in organisms. Even so, the structural data and the use of an unmodified bacterial enzyme make this a solid milestone on the road from novel chemistry to practical tools for health and industry.
